European Companies Search Engine
EU funding (€3,618,387): Machine Learning Frontiers in Precision Medicine Hor13 Nov 2018 EU Research and Innovation programme "Horizon"
Overview
Text
Machine Learning Frontiers in Precision Medicine
Healthcare is entering the digital era: More and more patient data, from the molecular level of genome sequences to the level of image phenotypes and health history, are available in digital form. Exploring this big health data promises to reveal new insights into disease mechanisms and therapy outcomes. Ultimately, the goal is to exploit these insights for Precision Medicine, which hopes to offer personalized preventive care and therapy selection for each patient. A technology with transformational potential in analysing this health data is Machine Learning. Machine Learning strives to discover new knowledge in form of statistical dependencies in large datasets. Mining health data is, however, not a simple direct application of established machine learning techniques. On the contrary, the emerging population-scale and ultra-high dimensionality of health data creates the need to develop Machine Learning algorithms that can successfully operate at this scale. Overcoming these frontiers in Machine Learning is key to making the vision of Precision Medicine a reality. To meet this challenge, Europe urgently needs a new generation of scientists with knowledge in both machine learning and in health data analysis, who are extremely rare at a global scale. Our ETN’s goal is to close this gap, by bringing together leading European research institutes in Machine Learning and Statistical Genetics, both from the private and public sector, to train 14 early stage researchers. These scientists will help to shape the future of this important topic and increase Europe’s competitiveness in this domain, which will have severe academic and industrial impact in the future and has the potential to shape the healthcare and high tech sector in Europe in the 21st century.
Funded Companies:
| Company name | Funding amount |
| Pharmatics Ltd. | ? |
| Association Pour la Recherche et le Developpement des Methodes et Processus Industriels | €274,802 |
| EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH | €562,553 |
| Fundacion Publica Andaluza Progreso y Salud M.P | €250,905 |
| IBM ISRAEL - SCIENCE AND TECHNOLOGY Ltd. | €263,501 |
| MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN e. V. | €505,577 |
| Qlucore AB | €281,983 |
| SIEMENS HEALTHCARE GmbH | €147,460 |
| STACC OÜ | €232,070 |
| TARTU ULIKOOL | €232,070 |
| Universidad Carlos III de Madrid | €250,905 |
| Universite de Liege | €341,760 |
| Universite Paris Cite | €274,802 |
Source: https://cordis.europa.eu/project/id/813533
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Pharmatics Ltd., Edinburgh.
The visualizations for "Pharmatics Ltd. - EU funding (€3,618,387): Machine Learning Frontiers in Precision Medicine"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
